Revolutionizing FinTech

From Tech Market Reporter | Ad

This firm has $25T potential in transforming the way China lends.

Click here now for all the details.

BTX Insider Trading (Brooklyn ImmunoTherapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $26.34

Insider Selling (Last 12 Months): $4,350,500.00

Brooklyn ImmunoTherapeutics Insider Trading History Chart

Brooklyn ImmunoTherapeutics Share Price & Price History

^$8.50

▼ -0.24 (-2.75%)

As of 10/27/2021 01:00 AM ET

Days: 30 | 90 | 365

Is this Seattle Penny Pot Stock a Potential Blockbuster?

From All Marijuana Stocks | Ad

A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.

Get Free Report on #1 Cannabis Pick for 2021

Brooklyn ImmunoTherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/14/2021	George P Denny III	Major Shareholder	Buy	1	$11.99	$11.99	4,094
7/8/2021	George P. Denny III	Major Shareholder	Buy	1	$14.35	$14.35	4,094
7/6/2021	George P. Denny III	Major Shareholder	Sell	75,000	$16.06	$1,204,500.00	4,094
6/16/2021	Charles Cherington	Director	Sell	200,000	$15.73	$3,146,000.00	6,094,101
8/14/2019	Broadwood Partners, L.P.	Director	Buy	1,407	$0.98	$1,378.86
8/13/2019	Brian M. Culley	CEO	Buy	10,000	$1.01	$10,100.00
8/13/2019	Chase C Leavitt	General Counsel	Buy	5,000	$1.02	$5,100.00	5,000
7/5/2019	Biotime Inc	Major Shareholder	Sell	2,250,000	$2.00	$4,500,000.00	12,424,244

Insider Trading at Brooklyn ImmunoTherapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Brooklyn ImmunoTherapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Brooklyn ImmunoTherapeutics (NYSEAMERICAN:BTX)

Institutional Buying and Selling by Quarter

Brooklyn ImmunoTherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/27/2021	Baldwin Brothers LLC MA	38,604	$0.36M	0.0%	-12.5%	0.075%
10/22/2021	Strs Ohio	6,800	$63K	0.0%	+23.6%	0.013%
8/23/2021	Morgan Stanley	16,584	$0.30M	0.0%	N/A	0.032%
8/17/2021	Metropolitan Life Insurance Co NY	8,272	$0.15M	0.0%	N/A	0.019%
8/17/2021	Millennium Management LLC	39,893	$0.72M	0.0%	N/A	0.090%
8/17/2021	MetLife Investment Management LLC	10,805	$0.20M	0.0%	N/A	0.024%
8/17/2021	Bridgeway Capital Management LLC	15,000	$0.27M	0.0%	-14.3%	0.034%
8/16/2021	Bank of America Corp DE	9,719	$0.18M	0.0%	+33,413.8%	0.022%
8/16/2021	California State Teachers Retirement System	32,852	$0.59M	0.0%	N/A	0.074%
8/16/2021	Royal Bank of Canada	1,636	$29K	0.0%	N/A	0.004%
8/16/2021	Morgan Stanley	16,584	$0.30M	0.0%	N/A	0.038%
8/16/2021	Charles Schwab Investment Management Inc.	58,249	$1.05M	0.0%	N/A	0.132%
8/16/2021	State Street Corp	439,095	$7.91M	0.0%	N/A	0.994%
8/16/2021	Nuveen Asset Management LLC	275,673	$4.97M	0.0%	N/A	0.624%
8/13/2021	Northern Trust Corp	230,529	$4.15M	0.0%	N/A	0.522%
8/13/2021	Geode Capital Management LLC	357,756	$6.44M	0.0%	+3,278.6%	0.810%
8/13/2021	Vanguard Group Inc.	409,098	$7.37M	0.0%	N/A	0.926%
8/12/2021	Legal & General Group Plc	2,441	$44K	0.0%	N/A	0.006%
8/12/2021	JPMorgan Chase & Co.	37,522	$0.68M	0.0%	N/A	0.085%
8/12/2021	The Manufacturers Life Insurance Company	14,004	$0.25M	0.0%	N/A	0.032%
8/11/2021	Bank of New York Mellon Corp	71,743	$1.29M	0.0%	N/A	0.162%
8/11/2021	BlackRock Inc.	1,402,891	$25.27M	0.0%	+92,868.3%	3.175%
8/11/2021	Deutsche Bank AG	15,128	$0.27M	0.0%	N/A	0.034%
8/10/2021	Inverness Counsel LLC NY	13,307	$0.24M	0.0%	N/A	0.030%
8/10/2021	Citigroup Inc.	1,433	$26K	0.0%	N/A	0.003%
8/6/2021	Ameritas Investment Partners Inc.	1,867	$34K	0.0%	N/A	0.004%
8/5/2021	Rhumbline Advisers	14,620	$0.26M	0.0%	N/A	0.033%
8/4/2021	Cypress Point Wealth Management LLC	471,878	$8.50M	6.0%	N/A	1.068%
8/3/2021	Montag A & Associates Inc.	1,427	$26K	0.0%	N/A	0.003%
8/2/2021	New York State Common Retirement Fund	20,400	$0.37M	0.0%	N/A	0.046%
8/1/2021	Baldwin Brothers Inc. MA	44,116	$0.80M	0.1%	N/A	0.100%
7/30/2021	Alliancebernstein L.P.	45,400	$0.82M	0.0%	N/A	0.103%
5/21/2021	Citadel Advisors LLC	22,849	$85K	0.0%	N/A	1.536%
5/19/2021	Virtu Financial LLC	18,248	$68K	0.0%	N/A	1.226%
5/18/2021	Citadel Advisors LLC	22,849	$85K	0.0%	N/A	1.536%
5/13/2021	Renaissance Technologies LLC	19,850	$74K	0.0%	N/A	1.334%
5/12/2021	Geode Capital Management LLC	10,589	$39K	0.0%	N/A	0.712%
8/20/2019	Defender Capital LLC.	4,119,800	$4.27M	3.5%	-2.2%	2.753%
8/15/2019	Zacks Investment Management	77,609	$85K	0.0%	N/A	0.052%
8/15/2019	Jane Street Group LLC	111,818	$0.12M	0.0%	-38.0%	0.075%
8/14/2019	Citadel Advisors LLC	114,117	$0.13M	0.0%	+10.2%	0.076%
8/14/2019	Morgan Stanley	46,879	$51K	0.0%	-28.4%	0.031%
8/14/2019	Vanguard Group Inc.	5,310,390	$5.84M	0.0%	+2.4%	3.549%
8/14/2019	A.R.T. Advisors LLC	29,731	$33K	0.0%	N/A	0.020%
8/13/2019	BlackRock Inc.	7,091,184	$7.80M	0.0%	-1.8%	4.739%
8/13/2019	Northern Trust Corp	1,243,382	$1.37M	0.0%	+0.9%	0.831%
8/12/2019	Bank of New York Mellon Corp	408,904	$0.45M	0.0%	-13.1%	0.273%
8/9/2019	Northeast Financial Consultants Inc	551,856	$0.61M	0.1%	+34.6%	0.369%
8/9/2019	Panagora Asset Management Inc.	334,914	$0.37M	0.0%	N/A	0.224%
8/8/2019	Acadian Asset Management LLC	23,346	$26K	0.0%	N/A	0.016%
6/30/2019	Creative Planning	227,392	$0.25M	0.0%	+52.2%	0.152%
6/30/2019	Beirne Wealth Consulting Services LLC	45,000	$50K	0.0%	+80.0%	0.030%
6/30/2019	Moors & Cabot Inc.	38,150	$41K	0.0%	+30.9%	0.025%
5/14/2019	Northeast Financial Consultants Inc	409,856	$0.54M	0.1%	N/A	0.274%
5/14/2019	Williams Jones & Associates LLC	102,111	$0.13M	0.0%	+26.5%	0.068%
5/10/2019	Price Capital Management Inc.	328,202	$0.43M	0.1%	N/A	0.219%
5/1/2019	Rhumbline Advisers	142,796	$0.19M	0.0%	+11.4%	0.096%
5/1/2019	Moors & Cabot Inc.	58,300	$76K	0.0%	+122.9%	0.039%
5/1/2019	Destination Wealth Management	500,245	$0.66M	0.0%	-4.9%	0.335%
4/25/2019	BNP Paribas Arbitrage SA	25,171	$33K	0.0%	+515.3%	0.017%
4/24/2019	Creative Planning	149,414	$0.20M	0.0%	N/A	0.100%
4/23/2019	Defender Capital LLC.	4,214,560	$5.57M	4.5%	+5.8%	2.822%
4/1/2019	Deutsche Bank AG	376,850	$0.34M	0.0%	+95.6%	0.252%
2/15/2019	Jane Street Group LLC	82,630	$76K	0.0%	+191.8%	0.065%
2/14/2019	Two Sigma Advisers LP	154,253	$0.14M	0.0%	+82.9%	0.121%
2/14/2019	Two Sigma Investments LP	529,977	$0.48M	0.0%	+265.9%	0.417%
2/13/2019	Geode Capital Management LLC	1,227,540	$1.12M	0.0%	+3.1%	0.967%
2/11/2019	Raymond James Financial Services Advisors Inc.	33,685	$31K	0.0%	-47.6%	0.027%
2/11/2019	Bank of New York Mellon Corp	408,881	$0.37M	0.0%	-46.5%	0.322%
2/8/2019	BlackRock Inc.	6,179,281	$5.64M	0.0%	+1.3%	4.867%
2/8/2019	Defender Capital LLC.	3,984,470	$3.63M	3.5%	N/A	3.138%
2/7/2019	LPL Financial LLC	51,504	$47K	0.0%	+383.4%	0.041%
2/4/2019	IndexIQ Advisors LLC	781,328	$0.72M	0.0%	-7.5%	0.615%
1/31/2019	Rhumbline Advisers	128,217	$0.12M	0.0%	+43.7%	0.101%
1/16/2019	Virtu Financial LLC	34,884	$32K	0.0%	+165.4%	0.027%
12/13/2018	Vanguard Group Inc	4,467,698	$10.50M	0.0%	+0.6%	3.519%
11/16/2018	TIAA CREF Investment Management LLC	356,200	$0.84M	0.0%	-20.8%	0.281%
11/16/2018	Teachers Advisors LLC	185,451	$0.44M	0.0%	+20.0%	0.146%
11/15/2018	IndexIQ Advisors LLC	845,072	$1.98M	0.1%	+3.9%	0.666%
11/14/2018	Jefferies Group LLC	117,571	$0.28M	0.0%	+273.0%	0.093%
11/13/2018	Bridgeway Capital Management Inc.	190,700	$0.45M	0.0%	+1,066.5%	0.150%
11/9/2018	BlackRock Inc.	6,102,467	$14.34M	0.0%	+3.1%	4.810%
11/8/2018	AXA	2,101,975	$4.94M	0.0%	-8.7%	1.657%
11/7/2018	Destination Wealth Management	526,245	$1.24M	0.1%	N/A	0.415%
9/18/2018	Northern Trust Corp	1,016,226	$2.09M	0.0%	+5.2%	0.801%
8/13/2018	Renaissance Technologies LLC	145,600	$0.30M	0.0%	-81.2%	0.115%
8/6/2018	Bank of New York Mellon Corp	744,554	$1.53M	0.0%	+4.7%	0.587%
5/16/2018	Millennium Management LLC	113,347	$0.31M	0.0%	-24.8%	0.089%
5/15/2018	DAFNA Capital Management LLC	181,600	$0.49M	0.2%	-34.0%	0.143%
5/9/2018	Northern Trust Corp	966,448	$2.60M	0.0%	+5.2%	0.762%
5/7/2018	Schwab Charles Investment Management Inc.	173,856	$0.47M	0.0%	+20.9%	0.137%
2/15/2018	Millennium Management LLC	150,721	$0.32M	0.0%	+938.4%	0.119%
2/14/2018	Two Sigma Investments LP	289,240	$0.62M	0.0%	+122.8%	0.228%
2/14/2018	Two Sigma Advisers LP	90,053	$0.19M	0.0%	+422.0%	0.071%
2/13/2018	Renaissance Technologies LLC	1,197,800	$2.58M	0.0%	+206.9%	0.944%
2/13/2018	AXA	2,298,681	$4.94M	0.0%	N/A	1.812%
2/13/2018	Geode Capital Management LLC	1,101,851	$2.37M	0.0%	+3.2%	0.868%
2/9/2018	Citadel Advisors LLC	148,814	$0.32M	0.0%	+90.8%	0.117%
2/9/2018	Destination Wealth Management	526,245	$1.13M	0.1%	-11.0%	0.415%
2/9/2018	Artal Group S.A.	1,557,050	$3.35M	0.1%	+21.5%	1.227%

Data available starting January 2016

Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company that develops IRX-2, a novel hd-IL-2 based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. In a Phase 2a clinical trial, IRX-2 demonstrated an increase in tumor infiltrating lymphocytes, which was associated with a survival benefit in patients with head and neck cancer. The company is headquartered in New York, NY.

Today's Range

Now: $8.50

$8.48

$8.80

50 Day Range

MA: N/A

52 Week Range

Now: $8.50

$3.59

$80.67

Volume

293,026 shs

Average Volume

4,143,336 shs

Market Capitalization

$439.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Brooklyn ImmunoTherapeutics?: Brooklyn ImmunoTherapeutics' top insider shareholders include:
Charles Cherington (Director)
George P Denny III (Major Shareholder)
Who are the major institutional investors of Brooklyn ImmunoTherapeutics?: Brooklyn ImmunoTherapeutics' top institutional shareholders include:
Baldwin Brothers LLC MA — 0.07%
Strs Ohio — 0.01%
Which institutional investors are selling Brooklyn ImmunoTherapeutics stock?: During the last quarter, BTX stock was sold by these institutional investors:
Baldwin Brothers LLC MA
In the previous year, company insiders that have sold Brooklyn ImmunoTherapeutics company stock include:
Charles Cherington (Director)
George P Denny III (Major Shareholder)
Which institutional investors are buying Brooklyn ImmunoTherapeutics stock?: During the previous quarter, BTX stock was bought by institutional investors including:
Strs Ohio

Fake meat? This company is cornering the plant-based market

From Stock Trends Today | Ad

This could become one of the greatest growth stories of our lifetimes

This tiny plant-based firm has explosive growth

Get the FREE investor deck